Denali Therapeutics Market Sentiment

Denali Therapeutics Inc

DNLINASDAQ

Trade with Public

$17.61

-0.73-3.98%

Ult. Agg.: Oct 19, 5:07 AM

$17.73

-0.61-3.33%

Panoramica Notizie Previsioni utili Eventi Obiettivi di prezzo Dati finanziariSentimentAzionariato Confronta Opzioni Rapporto azionario

Denali Therapeutics Market Sentiment

Market sentiment signals for Denali Therapeutics (DNLI): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 10.2% short float

Options Flow— N/A

Insider Activity— N/A

Analyst Consensus

Buy

23 analysts

Options Flow (P/C)

—

Avg Consensus PT

$35

+98.3%

Highest Price Target

$45

+153.8%

Jefferies

Lowest Price Target

$23

+29.7%

Wedbush

Short Interest

10.2%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Aug 25, 2026	B. Riley Securities	Mayank Mamtani—	+97.4%	$30 → $35	Maintained	Buy
Aug 7, 2026	UBS	Michael Yee—	+91.8%	$25 → $34	Maintained	Buy
Jul 23, 2026	Morgan Stanley	Matthew Harrison—	+103.0%	$35 → $36	Maintained	Overweight
Jul 16, 2026	Deutsche Bank	David Hoang—	+97.4%	$31 → $35	Maintained	Buy
Jul 13, 2026	JP Morgan	Jessica Fye—	+63.6%	$29	Reinstates	Overweight
May 26, 2026	Morgan Stanley	Matthew Harrison—	+97.4%	$40 → $35	Maintained	Overweight
May 14, 2026	Morgan Stanley	Matthew Harrison—	+125.6%	$42 → $40	Maintained	Overweight
May 11, 2026	BTIG	Thomas Shrader—	+120.0%	$39 → $39	Maintained	Buy
May 8, 2026	Wedbush	Laura Chico—	+29.7%	$25 → $23	Maintained	Outperform
Apr 22, 2026	Leerink Partners	Marc Goodman—	+97.4%	$40 → $35	Maintained	Outperform
Apr 7, 2026	Baird	Joel Beatty—	+91.8%	$32 → $34	Maintained	Outperform
Mar 26, 2026	Morgan Stanley	Matthew Harrison—	+136.9%	$40 → $42	Maintained	Overweight
Mar 26, 2026	Goldman Sachs	Salveen Richter—	+125.6%	$35 → $40	Maintained	Buy
Mar 26, 2026	Stifel	Paul Mattels—	+131.2%	$34 → $41	Maintained	Buy
Mar 26, 2026	Baird	Joel Beatty—	+80.5%	$29 → $32	Maintained	Outperform
Mar 26, 2026	HC Wainwright & Co.	Andrew S. Fein—	+136.9%	$32 → $42	Maintained	Buy
Mar 25, 2026	BTIG	Thomas Shrader—	+114.3%	$36 → $38	Maintained	Buy
Mar 2, 2026	BTIG	Thomas Shrader—	+103.0%	$32 → $36	Maintained	Buy
Feb 24, 2026	Wolfe Research	Rudy Li—	—	—	Initiate	Peer Perform
Feb 6, 2026	BTIG	Thomas Shrader—	+80.5%	$32 → $32	Maintained	Buy
Jan 7, 2026	UBS	Michael Yee—	+41.0%	$25	Assumes	Buy
Dec 11, 2025	Wedbush	Laura Chico—	+69.2%	$31 → $30	Maintained	Outperform
Dec 5, 2025	Wedbush	Laura Chico—	+74.8%	$30 → $31	Maintained	Outperform
Dec 5, 2025	BTIG	Thomas Shrader—	+80.5%	$32 → $32	Maintained	Buy
Nov 4, 2025	JP Morgan	Jessica Fye—	+46.6%	$24 → $26	Maintained	Overweight